An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators
about
Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodiesThe C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replicationMutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphomaThe B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell responseThe cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.A gammaherpesviral internal repeat contributes to latency amplification.A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.A subset of replication proteins enhances origin recognition and lytic replication by the Epstein-Barr virus ZEBRA protein.Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylationEpstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinasesRta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction.Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 RTA reactivates murine gammaherpesvirus 68 from latency.Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation.The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.MCAF1 and synergistic activation of the transcription of Epstein-Barr virus lytic genes by Rta and Zta.The DNA architectural protein HMGB1 displays two distinct modes of action that promote enhanceosome assembly.Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomesCharacterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replicationModeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 proteinPhysical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha.Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.T cell epitope clustering in the highly immunogenic BZLF1 antigen of Epstein-Barr virus.NF-kappaB inhibits gammaherpesvirus lytic replicationCellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latencycis-Acting effects on RNA processing and Drosha cleavage prevent Epstein-Barr virus latency III BHRF1 expression.Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial CellsThe Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replicationA replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator.Genome-wide analysis of Epstein-Barr virus Rta DNA bindingViral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanismActivation of the Epstein-Barr virus BMRF1 and BZLF1 promoters by ZEBRA in Saccharomyces cerevisiae
P2860
Q24529499-81B96533-0865-4800-93B6-4D713009E0B6Q24563120-8885EE30-26A9-4807-95E8-827C0AA290BFQ24671870-E0564AC9-2305-4163-8AC6-50D1EF6DA471Q28472086-4A19D428-C621-4320-BC7F-5323394A15BDQ28480586-77CEB402-0F92-455B-AB2B-4BCF5E0BF8BEQ28590981-1B4E4030-9D6F-4143-9634-F674EF15961BQ30442835-C442E149-E8B9-4257-A424-93101A7DA567Q30450300-6247026B-4B04-4622-9A6C-9204DD6C8502Q33294708-1C903009-AF8D-408E-BF6C-7C010846EC65Q33559699-12F35AA8-CBFE-4F1D-8302-1A1EC2F37289Q33680762-70072D0B-0848-4779-9967-5555392F3568Q33786869-E5AE834C-6F4E-4F48-9CA1-F851DF8702F4Q33793163-9C8D27F4-7A48-4D80-AF5C-6F3DDF14DFE5Q33802415-973FA3C3-6DE5-4A42-BAB6-39315E464ADDQ33817088-D0267E47-0164-4C2F-98B2-CCB67F436C8AQ33833909-0CC67852-D9EF-4318-8437-F22154A86D21Q33837983-1169B4AC-1E42-4468-A1E4-F2F6CC56E51DQ33842700-F4B554E5-DC6C-4799-8D59-E3A60A48C984Q33936163-44E54FAA-C07B-4406-8E2F-4077F2E7FE10Q34058394-A4A55B2E-8D41-48D0-AF00-F52155D30806Q34281562-069FBEF2-E606-4B03-942A-4AA68E53EDF0Q34337317-EC2D2903-83AB-4122-8DE5-11B91C3F1F2FQ34338900-8BA32603-8D6D-4662-A035-C9AF49B987B0Q34343562-6CEC4961-947F-407C-9314-0659CA3F4537Q34589844-7CB18A09-7E36-403E-908F-088F52A75A9FQ34751026-94DDB416-61F2-440F-8B17-DEA4266FF38EQ34981036-612DD24C-500F-43DD-B4A9-89B8FD71ECD0Q34992684-F3D8694E-1D84-44F1-A2AB-BEB692B82B87Q35155154-EB358F5A-E828-4DD9-B0F4-16317EDA102EQ35192797-67DC857A-EEBA-4256-933A-7C027C09764CQ35192847-2544409D-5B4B-4380-B7BA-A531E2F400C7Q35797164-962754C5-46DF-4763-B5F2-DEA9352E619DQ35839977-5F82D3FE-E9B4-4389-8423-C18D930BB292Q35859223-EB29998C-AA44-4F0D-891A-9E5DED4CBE26Q35865903-578B0F03-C398-472B-8588-F7930B1B3CE1Q35873179-BCF1B47F-32BC-4584-99E0-3677D0F4AEB4Q35943838-C85BCBCF-3A3F-42A7-A84D-5F51D626F266Q36559479-16B0400D-ABAF-472F-8349-CC4C9E816094Q36630074-4C33A8E9-82FB-4F33-8887-1D630CEB2A4AQ36637481-188AC014-D2FE-4AFD-88BE-363AE55A7FF6
P2860
An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
An enhancer within the diverge ...... to the R and Z transactivators
@en
type
label
An enhancer within the diverge ...... to the R and Z transactivators
@en
prefLabel
An enhancer within the diverge ...... to the R and Z transactivators
@en
P2093
P2860
P1433
P1476
An enhancer within the diverge ...... to the R and Z transactivators
@en
P2093
P2860
P304
P407
P577
1990-01-01T00:00:00Z